Publicaciones en las que colabora con Valentí Fuster (7)

2022

  1. Polypill Strategy in Secondary Cardiovascular Prevention

    The New England journal of medicine, Vol. 387, Núm. 11, pp. 967-977

  2. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

2021

  1. Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity

    Cardiovascular research, Vol. 117, Núm. 4, pp. 1132-1143

2019

  1. Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity

    Journal of the American College of Cardiology, Vol. 73, Núm. 7, pp. 779-791

2018

  1. Response by Fernández-Jiménez et al to Letters Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage"

    Circulation

2017

  1. Dynamic edematous response of the human heart to myocardial infarction: Implications for assessing myocardial area at risk and salvage

    Circulation, Vol. 136, Núm. 14, pp. 1288-1300

  2. Effect of Ischemia Duration and Protective Interventions on the Temporal Dynamics of Tissue Composition after Myocardial Infarction

    Circulation Research, Vol. 121, Núm. 4, pp. 439-450